Tumor Biology

, Volume 37, Issue 3, pp 3081–3090 | Cite as

The clinical significance of systemic inflammation score in esophageal squamous cell carcinoma

  • Lihui Han
  • Qingxu Song
  • Yibin Jia
  • Xuan Chen
  • Cong Wang
  • Pengxiang Chen
  • Rui Min
  • Yufeng Cheng
Original Article


The objective of this study was to investigate the clinical significance of systemic inflammation score (SIS) and prognostic nutritional index (PNI) in esophageal squamous cell carcinoma (ESCC) patients who underwent esophagectomy. Records from 206 patients with histologically diagnosed ESCC who underwent esophagectomy at Qilu Hospital of Shandong University from January 2007 to December 2008 were retrospectively reviewed. The median disease-free survival (DFS) of this cohort was 32.3 months and 5-year DFS was 34.5 %. The median overall survival (OS) was 39.5 months and 5-year OS was 40.8 %. We found that high SIS was significantly associated with increased tumor length (p = 0.021), increased depth of invasion (p = 0.001), lymph node metastasis (p = 0.038), and advanced pathological stage (p = 0.004). Kaplan–Meier survival analysis revealed that both high SIS and low PNI were significantly associated with inferior DFS (for the SIS, p = 0.005; for the PNI, p = 0.003) and OS (for the SIS, p = 0.007; for the PNI, p = 0.002). In multivariate analysis, SIS was an independent prognostic indicator for both DFS and OS. However, PNI was not an independent prognosticator in multivariate analysis. SIS was a novel and promising inflammation-based prognostic score than PNI in ESCC patients who underwent esophagectomy.


Esophageal cancer Squamous cell carcinoma Systemic inflammation score Prognostic nutritional index Prognosis 



This work was supported by Science and Technology Development Planning Project of Shandong Province (2014GSF118058).

Compliance with Ethical Standards

Conflicts of interest



  1. 1.
    Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108. doi: 10.3322/caac.21262.CrossRefPubMedGoogle Scholar
  2. 2.
    Lu CL, Lang HC, Luo JC, Liu CC, Lin HC, Chang FY, et al. Increasing trend of the incidence of esophageal squamous cell carcinoma, but not adenocarcinoma, in Taiwan. Cancer Causes Control. 2010;21(2):269–74. doi: 10.1007/s10552-009-9458-0.CrossRefPubMedGoogle Scholar
  3. 3.
    Liu J, Xie X, Zhou C, Peng S, Rao D, Fu J. Which factors are associated with actual 5-year survival of oesophageal squamous cell carcinoma? Eur J Cardiothorac Surg. 2012;41(3):e7–11. doi: 10.1093/ejcts/ezr240.CrossRefPubMedGoogle Scholar
  4. 4.
    Schwegler I, von Holzen A, Gutzwiller JP, Schlumpf R, Muhlebach S, Stanga Z. Nutritional risk is a clinical predictor of postoperative mortality and morbidity in surgery for colorectal cancer. Br J Surg. 2010;97(1):92–7. doi: 10.1002/bjs.6805.CrossRefPubMedGoogle Scholar
  5. 5.
    Buzby GP, Mullen JL, Matthews DC, Hobbs CL, Rosato EF. Prognostic nutritional index in gastrointestinal surgery. Am J Surg. 1980;139(1):160–7.  10.1016/0002-9610(80)90246-9.CrossRefPubMedGoogle Scholar
  6. 6.
    Sun K, Chen S, Xu J, Li G, He Y. The prognostic significance of the prognostic nutritional index in cancer: a systematic review and meta-analysis. J Cancer Res Clin Oncol. 2014;140(9):1537–49. doi: 10.1007/s00432-014-1714-3.CrossRefPubMedGoogle Scholar
  7. 7.
    Holgersson G, Sandelin M, Hoye E, Bergstrom S, Henriksson R, Ekman S, et al. Swedish lung cancer radiation study group: the prognostic value of anaemia, thrombocytosis and leukocytosis at time of diagnosis in patients with non-small cell lung cancer. Med Oncol. 2012;29(5):3176–82. doi: 10.1007/s12032-012-0247-3.CrossRefPubMedGoogle Scholar
  8. 8.
    Njolstad TS, Engerud H, Werner HM, Salvesen HB, Trovik J. Preoperative anemia, leukocytosis and thrombocytosis identify aggressive endometrial carcinomas. Gynecol Oncol. 2013;131(2):410–5. doi: 10.1016/j.ygyno.2013.08.032.CrossRefPubMedGoogle Scholar
  9. 9.
    Roxburgh CS, McMillan DC. Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol. 2010;6(1):149–63. doi: 10.2217/fon.09.136.CrossRefPubMedGoogle Scholar
  10. 10.
    Templeton AJ, McNamara MG, Seruga B, Vera-Badillo FE, Aneja P, Ocana A et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. Journal of the National Cancer Institute. 2014;106(6). doi: 10.1093/jnci/dju124.
  11. 11.
    Templeton AJ, Ace O, McNamara MG, Al-Mubarak M, Vera-Badillo FE, Hermanns T, et al. Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysis. Cancer Epidemiol Biomark Prev. 2014;23(7):1204–12. doi: 10.1158/1055-9965.epi-14-0146.CrossRefGoogle Scholar
  12. 12.
    Szkandera J, Gerger A, Liegl-Atzwanger B, Absenger G, Stotz M, Friesenbichler J, et al. The lymphocyte/monocyte ratio predicts poor clinical outcome and improves the predictive accuracy in patients with soft tissue sarcomas. Int J Cancer. 2014;135(2):362–70. doi: 10.1002/ijc.28677.CrossRefPubMedGoogle Scholar
  13. 13.
    Zhang GM, Zhu Y, Luo L, Wan FN, Zhu YP, Sun LJ, et al. Preoperative lymphocyte-monocyte and platelet-lymphocyte ratios as predictors of overall survival in patients with bladder cancer undergoing radical cystectomy. Tumour Biol. 2015. doi: 10.1007/s13277-015-3613-x.Google Scholar
  14. 14.
    Han LH, Jia YB, Song QX, Wang JB, Wang NN, Cheng YF. Prognostic significance of preoperative lymphocyte-monocyte ratio in patients with resectable esophageal squamous cell carcinoma. Asian Pac J Cancer Prev. 2015;16(6):2245–50.CrossRefPubMedGoogle Scholar
  15. 15.
    Chang Y, An H, Xu L, Zhu Y, Yang Y, Lin Z, et al. Systemic inflammation score predicts postoperative prognosis of patients with clear-cell renal cell carcinoma. Br J Cancer. 2015. doi: 10.1038/bjc.2015.241.Google Scholar
  16. 16.
    Nozoe T, Kimura Y, Ishida M, Saeki H, Korenaga D, Sugimachi K. Correlation of pre-operative nutritional condition with post-operative complications in surgical treatment for Oesophageal carcinoma. Eur J Surg Oncol. 2002;28(4):396–400.CrossRefPubMedGoogle Scholar
  17. 17.
    Feng JF, Chen QX. Significance of the prognostic nutritional index in patients with esophageal squamous cell carcinoma. Ther Clin Risk Manag. 2014;10:1–7. doi: 10.2147/tcrm.s56159.PubMedGoogle Scholar
  18. 18.
    Pinato DJ, North BV, Sharma R. A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI). Br J Cancer. 2012;106(8):1439–45. doi: 10.1038/bjc.2012.92.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Zitvogel L, Tesniere A, Kroemer G. Cancer despite immunosurveillance: immunoselection and immunosubversion. Nat Rev Immunol. 2006;6(10):715–27. doi: 10.1038/nri1936.CrossRefPubMedGoogle Scholar
  20. 20.
    Filip B, Scarpa M, Cavallin F, Cagol M, Alfieri R, Saadeh L, et al. Postoperative outcome after oesophagectomy for cancer: nutritional status is the missing ring in the current prognostic scores. Eur J Surg Oncol. 2015;41(6):787–94. doi: 10.1016/j.ejso.2015.02.014.CrossRefPubMedGoogle Scholar
  21. 21.
    Migita K, Takayama T, Saeki K, Matsumoto S, Wakatsuki K, Enomoto K, et al. The prognostic nutritional index predicts long-term outcomes of gastric cancer patients independent of tumor stage. Ann Surg Oncol. 2013;20(8):2647–54. doi: 10.1245/s10434-013-2926-5.CrossRefPubMedGoogle Scholar
  22. 22.
    Nozoe T, Kohno M, Iguchi T, Mori E, Maeda T, Matsukuma A, et al. The prognostic nutritional index can be a prognostic indicator in colorectal carcinoma. Surg Today. 2012;42(6):532–5. doi: 10.1007/s00595-011-0061-0.CrossRefPubMedGoogle Scholar
  23. 23.
    Kanda M, Fujii T, Kodera Y, Nagai S, Takeda S, Nakao A. Nutritional predictors of postoperative outcome in pancreatic cancer. Br J Surg. 2011;98(2):268–74. doi: 10.1002/bjs.7305.CrossRefPubMedGoogle Scholar
  24. 24.
    Chan AW, Chan SL, Wong GL, Wong VW, Chong CC, Lai PB, et al. Prognostic nutritional index (PNI) predicts tumor recurrence of very early/early stage hepatocellular carcinoma after surgical resection. Ann Surg Oncol. 2015. doi: 10.1245/s10434-015-4516-1.Google Scholar
  25. 25.
    Sun P, Zhang F, Chen C, An X, Li YH, Wang FH, et al. Comparison of the prognostic values of various nutritional parameters in patients with esophageal squamous cell carcinoma from southern china. J Thorac Dis. 2013;5(4):484–91. doi: 10.3978/j.issn.2072-1439.2013.08.38.PubMedPubMedCentralGoogle Scholar
  26. 26.
    Crumley AB, Stuart RC, McKernan M, McMillan DC. Is hypoalbuminemia an independent prognostic factor in patients with gastric cancer? World J Surg. 2010;34(10):2393–8. doi: 10.1007/s00268-010-0641-y.CrossRefPubMedGoogle Scholar
  27. 27.
    Ataseven B, du Bois A, Reinthaller A, Traut A, Heitz F, Aust S, et al. Pre-operative serum albumin is associated with post-operative complication rate and overall survival in patients with epithelial ovarian cancer undergoing cytoreductive surgery. Gynecol Oncol. 2015. doi: 10.1016/j.ygyno.2015.07.005.Google Scholar
  28. 28.
    Rosenberg SA. The immunotherapy of solid cancers based on cloning the genes encoding tumor-rejection antigens. Annu Rev Med. 1996;47:481–91. doi: 10.1146/ Scholar
  29. 29.
    Mlecnik B, Tosolini M, Kirilovsky A, Berger A, Bindea G, Meatchi T, et al. Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction. J Clin Oncol. 2011;29(6):610–8. doi: 10.1200/jco.2010.30.5425.CrossRefPubMedGoogle Scholar
  30. 30.
    Mantovani A, Schioppa T, Porta C, Allavena P, Sica A. Role of tumor-associated macrophages in tumor progression and invasion. Cancer Metastasis Rev. 2006;25(3):315–22. doi: 10.1007/s10555-006-9001-7.CrossRefPubMedGoogle Scholar
  31. 31.
    Huang Y, Feng JF. Low preoperative lymphocyte to monocyte ratio predicts poor cancer-specific survival in patients with esophageal squamous cell carcinoma. OncoTargets Ther. 2015;8:137–45. doi: 10.2147/ott.s73794.Google Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2015

Authors and Affiliations

  • Lihui Han
    • 1
  • Qingxu Song
    • 1
  • Yibin Jia
    • 1
  • Xuan Chen
    • 1
  • Cong Wang
    • 1
  • Pengxiang Chen
    • 1
  • Rui Min
    • 1
  • Yufeng Cheng
    • 1
  1. 1.Department of Radiation OncologyQilu Hospital of Shandong UniversityJinanChina

Personalised recommendations